| 8.51 Delayed Data As of 4:00pm ET |  +0.355 / +4.36%Today’s Change | 7.63 Today|||52-Week Range 19.84 | -51.01% Year-to-Date |
| Meridian Bioscience Inc (VIVO) Q4 2019 Earnings Call Transcript Nov 08 / MotleyFool.com - Paid Partner Content |
| Previous close | 8.15 |
| Today’s open | 8.15 |
| Day’s range | 8.06 - 8.56 |
| Volume | 455,734 |
| Average volume (3 months) | 293,923 |
| Market cap | $338.3M |
| Earnings growth (last year) | +10.49% |
| Earnings growth (this year) | -13.18% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +6.38% |
| P/E ratio | 14.2 |
| Price/Sales | 2.98 |
| Price/Book | 1.91 |
| Today’s change | Today’s % change | |
|---|---|---|
| OXFDOxford Immunotec Glo... | -0.31 | -1.84% |
| GALTGalectin Therapeutic... | -0.20 | -5.57% |
| ---- | ||
| VRMLVermillion Inc | -0.03 | -4.63% |
| Next reporting date | January 22, 2020 |
| EPS forecast (this quarter) | $0.07 |
| Annual revenue (last year) | $213.6M |
| Annual profit (last year) | $23.8M |
| Net profit margin | 11.17% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cincinnati, Ohio |
